Loading clinical trials...
Loading clinical trials...
A Study to Assess the Efficacy and Tolerability of Taranabant in Maintaining Weight Loss Induced by Diet in Obese Patients Followed by a 1-Year Extension
Conditions
Interventions
taranabant
Comparator: placebo
Start Date
October 1, 2006
Primary Completion Date
February 1, 2008
Completion Date
November 1, 2008
Last Updated
February 5, 2015
NCT07472881
NCT01143454
NCT07010757
NCT06223555
NCT06989203
NCT07237750
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions